Robert P. Gasparini
Direktor/Vorstandsmitglied bei HEALTHLYNKED CORP.
Vermögen: 149 770 $ am 31.05.2024
Aktive Positionen von Robert P. Gasparini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HEALTHLYNKED CORP. | Direktor/Vorstandsmitglied | 30.04.2019 | - |
Independent Dir/Board Member | 30.04.2019 | - | |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Direktor/Vorstandsmitglied | 08.12.2022 | - |
Karriereverlauf von Robert P. Gasparini
Ehemalige bekannte Positionen von Robert P. Gasparini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEOGENOMICS, INC. | Direktor/Vorstandsmitglied | 01.01.2004 | 04.08.2014 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 04.08.2014 | |
Präsident | 01.01.2004 | 04.08.2014 | |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | 01.01.2004 | 01.01.2014 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2014 | |
Corporate Officer/Principal | 01.01.2001 | 01.01.2004 | |
Präsident | 01.01.2004 | 01.01.2014 | |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Vertrieb & Marketing | 01.01.1998 | 01.01.2001 |
Prenatal Diagnostic Center | Corporate Officer/Principal | 01.01.1993 | 01.01.1997 |
Tufts University | Corporate Officer/Principal | 01.01.1990 | 01.01.1993 |
University of Connecticut | Corporate Officer/Principal | 01.01.1985 | 01.01.1993 |
Ausbildung von Robert P. Gasparini
University of Connecticut | Undergraduate Degree |
Quinnipiac University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Consumer Services | 4 |
Health Services | 3 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NEOGENOMICS, INC. | Health Services |
HEALTHLYNKED CORP. | Technology Services |
Private Unternehmen | 4 |
---|---|
Prenatal Diagnostic Center | |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Services |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
- Börse
- Insiders
- Robert P. Gasparini
- Erfahrung